Arizona Cancer Center Biospecimen Repository

• Sponsor: University of Arizona (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT00896935
• Collaborator: National Cancer Institute (NCI) (NIH)
• Enrollment: 10,000
• Location: 1
• Duration (Months): 288
• Patients Per Site Per Month: 34.7

Study Details

Study Description

Brief Summary

RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.

Condition or Disease	Intervention/Treatment	Phase
Cancer	Other: biologic sample preservation procedure

Detailed Description

OBJECTIVES:

• Provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer.

• Collect and preserve tissue from the primary organ site (uninvolved and involved with cancer), from the metastases, from patient blood (serum and lymphocytes), and from patient urine.

• Provide quality-controlled storage and management of the specimen bank.

• Collect relevant clinical and pathologic information with appropriate privacy protection.

• Contribute to the development of a comprehensive database annotated with relevant clinical data, pathology, and research findings.

OUTLINE: This is a multicenter study.

Tumor samples, lymph node samples, and normal pancreas tissue samples are collected. Blood samples are also collected prior to surgery, six months after the initial blood draw and tissue sample collection, and every six months thereafter for two years.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 10000 participants
• Observational Model: Other
• Time Perspective: Other
• Official Title: Arizona Cancer Center Biospecimen Repository
• Study Start Date: Jul 1, 2006
• Anticipated Primary Completion Date: Jul 1, 2030
• Anticipated Study Completion Date: Jul 1, 2030

Outcome Measures

Primary Outcome Measures

1. Provision of tissue samples and biospecimens for translational study [July 2024]

   An electronic record of the specimens is kept in a secure, web-based database. Follow-up information from patients will be obtained from the patient medical record, and updated every 6 months

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

DISEASE CHARACTERISTICS:

• Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer

PATIENT CHARACTERISTICS:

• NA

PRIOR CONCURRENT THERAPY:

• NA

As this is a biospecimen repository, participation is open to all cancer patients being treated at the Arizona Cancer Center or University Medical Center by investigators on this protocol.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Arizona Cancer Center at University of Arizona Health Sciences Center	Tucson	Arizona	United States	85724-5024

Sponsors and Collaborators

• University of Arizona
• National Cancer Institute (NCI)

Investigators

• Principal Investigator: Setsuko K. Chambers, MD, University of Arizona

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

• Clinical trial summary from the National Cancer Institute's PDQ® database

Publications

None provided.

• Responsible Party: University of Arizona
• ClinicalTrials.gov Identifier: NCT00896935
• Other Study ID Numbers: CDR0000597579; P30CA023074; UARIZ-06-0609-04; UARIZ-BIO#A06035; UARIZ-SRC18042
• First Posted: May 12, 2009
• Last Update Posted: Aug 5, 2022
• Last Verified: Aug 1, 2022

• Keywords provided by University of Arizona: cancer

Study Results

No Results Posted as of Aug 5, 2022